A routine change in the inpatient obstetric providers resulted in a change from continued vaginal misoprostol to use of vaginal 10 mg dinoprostone (Cervidil) for cervical ripening. This change in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback